Exelixis
EXEL
#1730
Rank
HK$76.25 B
Marketcap
HK$272.45
Share price
1.48%
Change (1 day)
69.21%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company